TABLE 1.
Characteristics of the included studies
| Study ID | Country | Sample size | Age | Gender | Diagnosis of dengue | Diagnosis of COVID‐19 | Outcome | ICU admission | Hospital stay (days) |
|---|---|---|---|---|---|---|---|---|---|
| Irwinda‐2021 | Indonesia | 1 | 23 | F | NS1 antigen or IgM DENV | PCR | Died | Yes | 5 |
| Alam‐2021 | Indonesia | 1 | 10 months | F | NS1 antigen | PCR | Survived | No | 16 |
| Hariadi‐2021 | Indonesia | 1 | 68 | F | DENV IgM and IgG | PCR | Survived | No | 11 |
| Verduyn‐2020 | France | 1 | 18 | M | NS1 antigen | PCR | Survived | No | 7 |
| Khalil‐2020 | Saudi Arabia | 1 | 63 | M | NS1 antigen and IgG DENV | PCR | Survived | No | 6 |
| 1 | 53 | F | DENV IgM, IgG and PRC | PCR | Survived | No | 5 | ||
| 1 | 48 | F | NS1 antigen, IgM and IgG DENV | PCR | Survived | No | 4 | ||
| 1 | 46 | M | NS1 antigen and PCR | PCR | Survived | No | 0 | ||
| Malibari‐2020 | Saudi Arabia | 1 | 58 | M | NS1 antigen, IgM and IgG DENV | PCR | Survived | No | 7 |
| Reyes‐Ruiz‐2021 | Mexico | 1 | 42 | F | PCR | PCR | Survived | No | 18 |
| Wahiduzzaman‐2021 | Bangladesh | 1 | 34 | M | NS1 antigen | PCR | Survived | No | ‐ |
| Gupta‐2021 | India | 1 | 65 | M | DENV IgM | PCR | Survived | No | 17 |
| Kasi‐2020 | India | 1 | 9 months | F | NS1 antigen, IgM DENV | PCR | Survived | No | 14 |
| Kariyappa‐2021 | India | 1 | 5 months | F | DENV IgM and ELISA | PCR | Survived | No | 21 |
| Mahajan‐2020 | India | 1 | 22 | F | NS1 antigen | PCR | Survived | No | 9 |
| Krishna‐2021 | India | 1 | 28 | F | NS1 antigen, IgM DENV | PCR | Survived | No | 7 |
| Estofolete‐2020 | Brazil | 1 | 60 | F | NS1 antigen, IgM and IgG DENV | PCR | Died | Yes | 5 |
| Bicudo‐2020 | Brazil | 1 | 56 | F | NS1 antigen, IgM and IgG DENV | PCR | Survived | No | 6 |
| Pontes‐2020 | Brazil | 1 | 39 | M | PCR | PCR | Survived | No | ‐ |
| Rojas‐2021 | Colombia | 1 | 24 | F | NS1 antigen and PCR | PCR | Survived | Yes | 6 |
| 1 | 59 | M | DENV IgM and IgG | IgG SARS‐CoV‐2 | Died | Yes | 63 | ||
| Villamil‐Gómez‐2021 | Colombia | 1 | 52 | M | DENV IgM and IgG | PCR | Survived | No | 7 |
| Nasomsong‐2021 | Thailand | 1 | 50 | F | PCR | PCR | Survived | No | 11 |
| Roso‐2021 | Argentina | 1 | 57 | F | PCR | PCR | Survived | No | 5 |
| Carosella‐2021 | Argentina | 13 | 37 (29–50) a | 6 F, 7 M | NS1 antigen, PCR or serologic conversion | PCR | All survived | 0 patients | 12 (10–14) a |
| Radisic‐2020 | Argentina | 1 | 25 | M | NS1 antigen, IgM DENV | PCR | Survived | No | 8 |
| Saipen‐2021 | Philippines | 1 | 62 | F | NS1 antigen, IgG DENV | PCR | Survived | No | 9 |
| Mejía‐Parra‐2021 | Peru | 50 | 55.5 (40.5–65) a | 11 F, 39 M | PCR, NS1 antigen, IgM and IgG DENV | PCR, IgM and IgG SARS‐CoV‐2 | 14 died | 3 patients | ‐ |
Abbreviations: M, male; F, female.
a
Median (IQR).